Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

So far, benefits associated with consistent GLP-1 use in curbing medical spending lack sufficient data-backed evidence. It’s ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...